table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2030)
1.4.2 East Asia Market States and Outlook (2023-2030)
1.4.3 Europe Market States and Outlook (2023-2030)
1.4.4 South Asia Market States and Outlook (2023-2030)
1.4.5 Southeast Asia Market States and Outlook (2023-2030)
1.4.6 Middle East Market States and Outlook (2023-2030)
1.4.7 Africa Market States and Outlook (2023-2030)
1.4.8 Oceania Market States and Outlook (2023-2030)
1.4.9 South America Market States and Outlook (2023-2030)
1.5 Global Therapeutic Protein Market Size Analysis from 2023 to 2030
1.5.1 Global Therapeutic Protein Market Size Analysis from 2023 to 2030 by Consumption Volume
1.5.2 Global Therapeutic Protein Market Size Analysis from 2023 to 2030 by Value
1.5.3 Global Therapeutic Protein Price Trends Analysis from 2023 to 2030
1.6 COVID-19 Outbreak: Therapeutic Protein Industry Impact
Chapter 2 Global Therapeutic Protein Competition by Types, Applications, and Top Regions and Countries
2.1 Global Therapeutic Protein (Volume and Value) by Type
2.1.1 Global Therapeutic Protein Consumption and Market Share by Type (2017-2022)
2.1.2 Global Therapeutic Protein Revenue and Market Share by Type (2017-2022)
2.2 Global Therapeutic Protein (Volume and Value) by Application
2.2.1 Global Therapeutic Protein Consumption and Market Share by Application (2017-2022)
2.2.2 Global Therapeutic Protein Revenue and Market Share by Application (2017-2022)
2.3 Global Therapeutic Protein (Volume and Value) by Regions
2.3.1 Global Therapeutic Protein Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Therapeutic Protein Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Therapeutic Protein Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Therapeutic Protein Consumption by Regions (2017-2022)
4.2 North America Therapeutic Protein Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Therapeutic Protein Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Therapeutic Protein Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Therapeutic Protein Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Therapeutic Protein Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Therapeutic Protein Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Therapeutic Protein Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Therapeutic Protein Sales, Consumption, Export, Import (2017-2022)
4.10 South America Therapeutic Protein Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Therapeutic Protein Market Analysis
5.1 North America Therapeutic Protein Consumption and Value Analysis
5.1.1 North America Therapeutic Protein Market Under COVID-19
5.2 North America Therapeutic Protein Consumption Volume by Types
5.3 North America Therapeutic Protein Consumption Structure by Application
5.4 North America Therapeutic Protein Consumption by Top Countries
5.4.1 United States Therapeutic Protein Consumption Volume from 2017 to 2022
5.4.2 Canada Therapeutic Protein Consumption Volume from 2017 to 2022
5.4.3 Mexico Therapeutic Protein Consumption Volume from 2017 to 2022
Chapter 6 East Asia Therapeutic Protein Market Analysis
6.1 East Asia Therapeutic Protein Consumption and Value Analysis
6.1.1 East Asia Therapeutic Protein Market Under COVID-19
6.2 East Asia Therapeutic Protein Consumption Volume by Types
6.3 East Asia Therapeutic Protein Consumption Structure by Application
6.4 East Asia Therapeutic Protein Consumption by Top Countries
6.4.1 China Therapeutic Protein Consumption Volume from 2017 to 2022
6.4.2 Japan Therapeutic Protein Consumption Volume from 2017 to 2022
6.4.3 South Korea Therapeutic Protein Consumption Volume from 2017 to 2022
Chapter 7 Europe Therapeutic Protein Market Analysis
7.1 Europe Therapeutic Protein Consumption and Value Analysis
7.1.1 Europe Therapeutic Protein Market Under COVID-19
7.2 Europe Therapeutic Protein Consumption Volume by Types
7.3 Europe Therapeutic Protein Consumption Structure by Application
7.4 Europe Therapeutic Protein Consumption by Top Countries
7.4.1 Germany Therapeutic Protein Consumption Volume from 2017 to 2022
7.4.2 UK Therapeutic Protein Consumption Volume from 2017 to 2022
7.4.3 France Therapeutic Protein Consumption Volume from 2017 to 2022
7.4.4 Italy Therapeutic Protein Consumption Volume from 2017 to 2022
7.4.5 Russia Therapeutic Protein Consumption Volume from 2017 to 2022
7.4.6 Spain Therapeutic Protein Consumption Volume from 2017 to 2022
7.4.7 Netherlands Therapeutic Protein Consumption Volume from 2017 to 2022
7.4.8 Switzerland Therapeutic Protein Consumption Volume from 2017 to 2022
7.4.9 Poland Therapeutic Protein Consumption Volume from 2017 to 2022
Chapter 8 South Asia Therapeutic Protein Market Analysis
8.1 South Asia Therapeutic Protein Consumption and Value Analysis
8.1.1 South Asia Therapeutic Protein Market Under COVID-19
8.2 South Asia Therapeutic Protein Consumption Volume by Types
8.3 South Asia Therapeutic Protein Consumption Structure by Application
8.4 South Asia Therapeutic Protein Consumption by Top Countries
8.4.1 India Therapeutic Protein Consumption Volume from 2017 to 2022
8.4.2 Pakistan Therapeutic Protein Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Therapeutic Protein Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Therapeutic Protein Market Analysis
9.1 Southeast Asia Therapeutic Protein Consumption and Value Analysis
9.1.1 Southeast Asia Therapeutic Protein Market Under COVID-19
9.2 Southeast Asia Therapeutic Protein Consumption Volume by Types
9.3 Southeast Asia Therapeutic Protein Consumption Structure by Application
9.4 Southeast Asia Therapeutic Protein Consumption by Top Countries
9.4.1 Indonesia Therapeutic Protein Consumption Volume from 2017 to 2022
9.4.2 Thailand Therapeutic Protein Consumption Volume from 2017 to 2022
9.4.3 Singapore Therapeutic Protein Consumption Volume from 2017 to 2022
9.4.4 Malaysia Therapeutic Protein Consumption Volume from 2017 to 2022
9.4.5 Philippines Therapeutic Protein Consumption Volume from 2017 to 2022
9.4.6 Vietnam Therapeutic Protein Consumption Volume from 2017 to 2022
9.4.7 Myanmar Therapeutic Protein Consumption Volume from 2017 to 2022
Chapter 10 Middle East Therapeutic Protein Market Analysis
10.1 Middle East Therapeutic Protein Consumption and Value Analysis
10.1.1 Middle East Therapeutic Protein Market Under COVID-19
10.2 Middle East Therapeutic Protein Consumption Volume by Types
10.3 Middle East Therapeutic Protein Consumption Structure by Application
10.4 Middle East Therapeutic Protein Consumption by Top Countries
10.4.1 Turkey Therapeutic Protein Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Therapeutic Protein Consumption Volume from 2017 to 2022
10.4.3 Iran Therapeutic Protein Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Therapeutic Protein Consumption Volume from 2017 to 2022
10.4.5 Israel Therapeutic Protein Consumption Volume from 2017 to 2022
10.4.6 Iraq Therapeutic Protein Consumption Volume from 2017 to 2022
10.4.7 Qatar Therapeutic Protein Consumption Volume from 2017 to 2022
10.4.8 Kuwait Therapeutic Protein Consumption Volume from 2017 to 2022
10.4.9 Oman Therapeutic Protein Consumption Volume from 2017 to 2022
Chapter 11 Africa Therapeutic Protein Market Analysis
11.1 Africa Therapeutic Protein Consumption and Value Analysis
11.1.1 Africa Therapeutic Protein Market Under COVID-19
11.2 Africa Therapeutic Protein Consumption Volume by Types
11.3 Africa Therapeutic Protein Consumption Structure by Application
11.4 Africa Therapeutic Protein Consumption by Top Countries
11.4.1 Nigeria Therapeutic Protein Consumption Volume from 2017 to 2022
11.4.2 South Africa Therapeutic Protein Consumption Volume from 2017 to 2022
11.4.3 Egypt Therapeutic Protein Consumption Volume from 2017 to 2022
11.4.4 Algeria Therapeutic Protein Consumption Volume from 2017 to 2022
11.4.5 Morocco Therapeutic Protein Consumption Volume from 2017 to 2022
Chapter 12 Oceania Therapeutic Protein Market Analysis
12.1 Oceania Therapeutic Protein Consumption and Value Analysis
12.2 Oceania Therapeutic Protein Consumption Volume by Types
12.3 Oceania Therapeutic Protein Consumption Structure by Application
12.4 Oceania Therapeutic Protein Consumption by Top Countries
12.4.1 Australia Therapeutic Protein Consumption Volume from 2017 to 2022
12.4.2 New Zealand Therapeutic Protein Consumption Volume from 2017 to 2022
Chapter 13 South America Therapeutic Protein Market Analysis
13.1 South America Therapeutic Protein Consumption and Value Analysis
13.1.1 South America Therapeutic Protein Market Under COVID-19
13.2 South America Therapeutic Protein Consumption Volume by Types
13.3 South America Therapeutic Protein Consumption Structure by Application
13.4 South America Therapeutic Protein Consumption Volume by Major Countries
13.4.1 Brazil Therapeutic Protein Consumption Volume from 2017 to 2022
13.4.2 Argentina Therapeutic Protein Consumption Volume from 2017 to 2022
13.4.3 Columbia Therapeutic Protein Consumption Volume from 2017 to 2022
13.4.4 Chile Therapeutic Protein Consumption Volume from 2017 to 2022
13.4.5 Venezuela Therapeutic Protein Consumption Volume from 2017 to 2022
13.4.6 Peru Therapeutic Protein Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Therapeutic Protein Consumption Volume from 2017 to 2022
13.4.8 Ecuador Therapeutic Protein Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Therapeutic Protein Business
14.1 Amgen
14.1.1 Amgen Company Profile
14.1.2 Amgen Therapeutic Protein Product Specification
14.1.3 Amgen Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Abbott Laboratories
14.2.1 Abbott Laboratories Company Profile
14.2.2 Abbott Laboratories Therapeutic Protein Product Specification
14.2.3 Abbott Laboratories Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 AstraZeneca
14.3.1 AstraZeneca Company Profile
14.3.2 AstraZeneca Therapeutic Protein Product Specification
14.3.3 AstraZeneca Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Baxter International
14.4.1 Baxter International Company Profile
14.4.2 Baxter International Therapeutic Protein Product Specification
14.4.3 Baxter International Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Boehringer Ingelheim
14.5.1 Boehringer Ingelheim Company Profile
14.5.2 Boehringer Ingelheim Therapeutic Protein Product Specification
14.5.3 Boehringer Ingelheim Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Chugai Pharmaceutical
14.6.1 Chugai Pharmaceutical Company Profile
14.6.2 Chugai Pharmaceutical Therapeutic Protein Product Specification
14.6.3 Chugai Pharmaceutical Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Diasome Pharmaceuticals
14.7.1 Diasome Pharmaceuticals Company Profile
14.7.2 Diasome Pharmaceuticals Therapeutic Protein Product Specification
14.7.3 Diasome Pharmaceuticals Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Eli Lilly
14.8.1 Eli Lilly Company Profile
14.8.2 Eli Lilly Therapeutic Protein Product Specification
14.8.3 Eli Lilly Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 GeneScience Pharmaceuticals
14.9.1 GeneScience Pharmaceuticals Company Profile
14.9.2 GeneScience Pharmaceuticals Therapeutic Protein Product Specification
14.9.3 GeneScience Pharmaceuticals Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Generex Biotechnology
14.10.1 Generex Biotechnology Company Profile
14.10.2 Generex Biotechnology Therapeutic Protein Product Specification
14.10.3 Generex Biotechnology Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Genentech
14.11.1 Genentech Company Profile
14.11.2 Genentech Therapeutic Protein Product Specification
14.11.3 Genentech Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Therapeutic Protein Market Forecast (2023-2030)
15.1 Global Therapeutic Protein Consumption Volume, Revenue and Price Forecast (2023-2030)
15.1.1 Global Therapeutic Protein Consumption Volume and Growth Rate Forecast (2023-2030)
15.1.2 Global Therapeutic Protein Value and Growth Rate Forecast (2023-2030)
15.2 Global Therapeutic Protein Consumption Volume, Value and Growth Rate Forecast by Region (2023-2030)
15.2.1 Global Therapeutic Protein Consumption Volume and Growth Rate Forecast by Regions (2023-2030)
15.2.2 Global Therapeutic Protein Value and Growth Rate Forecast by Regions (2023-2030)
15.2.3 North America Therapeutic Protein Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.4 East Asia Therapeutic Protein Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.5 Europe Therapeutic Protein Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.6 South Asia Therapeutic Protein Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.7 Southeast Asia Therapeutic Protein Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.8 Middle East Therapeutic Protein Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.9 Africa Therapeutic Protein Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.10 Oceania Therapeutic Protein Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.11 South America Therapeutic Protein Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.3 Global Therapeutic Protein Consumption Volume, Revenue and Price Forecast by Type (2023-2030)
15.3.1 Global Therapeutic Protein Consumption Forecast by Type (2023-2030)
15.3.2 Global Therapeutic Protein Revenue Forecast by Type (2023-2030)
15.3.3 Global Therapeutic Protein Price Forecast by Type (2023-2030)
15.4 Global Therapeutic Protein Consumption Volume Forecast by Application (2023-2030)
15.5 Therapeutic Protein Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
